Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
106,851,987
-
Number of holders
-
118
-
Total 13F shares, excl. options
-
64,348,842
-
Shares change
-
-1,763,180
-
Total reported value, excl. options
-
$200,754,799
-
Value change
-
-$8,031,870
-
Put/Call ratio
-
10.33%
-
Number of buys
-
57
-
Number of sells
-
-49
-
Price
-
$3.12
Significant Holders of MAXCYTE, INC. - Common Stock, par value $0.01 per share (MXCT) as of Q3 2023
131 filings reported holding MXCT - MAXCYTE, INC. - Common Stock, par value $0.01 per share as of Q3 2023.
MAXCYTE, INC. - Common Stock, par value $0.01 per share (MXCT) has 118 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 64,348,842 shares
of 106,851,987 outstanding shares and own 60.22% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6,887,996 shares), Vitruvian Partners LLP (5,043,356 shares), VANGUARD GROUP INC (5,038,847 shares), MILLENNIUM MANAGEMENT LLC (3,846,641 shares), Stonepine Capital Management, LLC (3,761,640 shares), ArrowMark Colorado Holdings LLC (2,409,038 shares), Portolan Capital Management, LLC (2,143,666 shares), Holocene Advisors, LP (2,117,228 shares), Granahan Investment Management, LLC (1,975,847 shares), and GEODE CAPITAL MANAGEMENT, LLC (1,973,437 shares).
This table shows the top 118 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.